ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:ACT • DE000A2YNT30
154.6 EUR
-2.8 (-1.78%)
Last: Jan 30, 2026, 07:00 PM
We assign a fundamental rating of 7 out of 10 to ACT. ACT was compared to 71 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACT is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, ACT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- ACT had positive earnings in the past year.
- In the past year ACT had a positive cash flow from operations.
- ACT had positive earnings in each of the past 5 years.
- ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 10.49%, ACT belongs to the top of the industry, outperforming 94.37% of the companies in the same industry.
- ACT has a better Return On Equity (26.47%) than 94.37% of its industry peers.
- ACT's Return On Invested Capital of 13.45% is amongst the best of the industry. ACT outperforms 91.55% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ACT is above the industry average of 7.18%.
- The last Return On Invested Capital (13.45%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
- ACT has a Profit Margin of 10.97%. This is amongst the best in the industry. ACT outperforms 81.69% of its industry peers.
- ACT's Profit Margin has improved in the last couple of years.
- ACT has a Operating Margin of 15.93%. This is amongst the best in the industry. ACT outperforms 83.10% of its industry peers.
- In the last couple of years the Operating Margin of ACT has grown nicely.
- The Gross Margin of ACT (66.55%) is better than 97.18% of its industry peers.
- ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
- ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for ACT has been reduced compared to 1 year ago.
- ACT has less shares outstanding than it did 5 years ago.
- ACT has a better debt/assets ratio than last year.
2.2 Solvency
- ACT has an Altman-Z score of 5.04. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
- ACT has a better Altman-Z score (5.04) than 88.73% of its industry peers.
- The Debt to FCF ratio of ACT is 1.32, which is an excellent value as it means it would take ACT, only 1.32 years of fcf income to pay off all of its debts.
- ACT has a Debt to FCF ratio of 1.32. This is amongst the best in the industry. ACT outperforms 94.37% of its industry peers.
- A Debt/Equity ratio of 0.16 indicates that ACT is not too dependend on debt financing.
- ACT has a better Debt to Equity ratio (0.16) than 71.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 5.04 |
ROIC/WACC1.85
WACC7.29%
2.3 Liquidity
- ACT has a Current Ratio of 2.87. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.87, ACT belongs to the top of the industry, outperforming 83.10% of the companies in the same industry.
- ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.77, ACT belongs to the top of the industry, outperforming 83.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
- ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.12%, which is quite impressive.
- Measured over the past years, ACT shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.60% on average per year.
- Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.05% in the last year.
- The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
- The Earnings Per Share is expected to grow by 20.26% on average over the next years. This is a very strong growth
- Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y21.07%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
EPS Next 5Y20.26%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 25.34 indicates a quite expensive valuation of ACT.
- ACT's Price/Earnings is on the same level as the industry average.
- When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (28.32), we can say ACT is valued inline with the index average.
- The Price/Forward Earnings ratio is 23.89, which indicates a rather expensive current valuation of ACT.
- ACT's Price/Forward Earnings is on the same level as the industry average.
- ACT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.34 | ||
| Fwd PE | 23.89 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ACT is valued a bit more expensive than the industry average as 60.56% of the companies are valued more cheaply.
- ACT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.98 | ||
| EV/EBITDA | 13.26 |
4.3 Compensation for Growth
- ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ACT may justify a higher PE ratio.
- A more expensive valuation may be justified as ACT's earnings are expected to grow with 18.06% in the coming years.
PEG (NY)1.2
PEG (5Y)1.03
EPS Next 2Y12.7%
EPS Next 3Y18.06%
5. Dividend
5.1 Amount
- ACT has a Yearly Dividend Yield of 1.14%.
- ACT's Dividend Yield is slightly below the industry average, which is at 2.46.
- ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
5.2 History
- The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 49.16% of the earnings are spent on dividend by ACT. This is a bit on the high side, but may be sustainable.
- The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status for ACT stock?
ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
Can you provide the financial health for ACT stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.
What is the earnings growth outlook for ALZCHEM GROUP AG?
The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 21.07% in the next year.